FDA Approved: USTEKINUMAB — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved ustekinumab (brand name Stelara) in its original application for the treatment of moderate to severe plaque psoriasis in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Stelara (ustekinumab)
• USTEKINUMAB (USTEKINUMAB)

Snippet

ORIG AP for USTEKINUMAB (USTEKINUMAB)